← Back
$TNYA All transactions

Tenaya Therapeutics, Inc.

A

$ Value

$0

Shares

952,250

Price

$0

Filed

Feb 5

Insider

Name

Ali Faraz

Title

Chief Executive Officer

CIK

0001667937

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-03

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

952,250

Footnotes

Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock. | The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested. | Includes 369,875 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. | Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.

Filing Info

Accession No.

0001193125-26-039760

Form Type

4

Issuer CIK

0001858848

Ali Faraz's History

Date Ticker Type Value
2026-02-17 TNYA $4K
2026-02-17 TNYA $3K
2026-02-17 TNYA $3K
2026-02-03 TNYA A $0
2026-02-03 TNYA A $0
2025-11-17 TNYA $4K
2025-08-18 TNYA $7K
2025-08-18 TNYA $5K
2025-08-18 TNYA $6K
2025-05-16 TNYA $1K

Other Insiders at TNYA (90d)

Insider Bought Sold Last
Ali Faraz
Chief Executive Officer
$10K 2026-02-17
COLUMN GROUP III GP, LP $5.9M 2026-02-25
Tingley Whittemore
Chief Medical Officer
$3K 2026-02-17
Higa Tomohiro
SVP, Finance
$2K 2026-02-17